Breast cancer is a heterogeneous disease with multiple molecular subtypes, among which the overexpression of human epidermal growth factor receptor 2 (HER2) plays a crucial role in prognosis and treatment strategies. The gene discussed is ERBB2; the disease is breast carcinoma.